L - PHARMA
ActiveSummary
L - PHARMA has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€509,185) and a net result of -€3,853. Equity remains stable across the filed financial years (±0.5% per year). Its solvency ranks better than 5% of 60 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Directors
Directors
No sitting directors in the Gazette act read. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.